0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Electroporated Competent Cells Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-11B16997
Home | Market Reports | Science| Biological Sciences
Global Electroporated Competent Cells Market Research Report 2024
BUY CHAPTERS

Global Electroporated Competent Cells Market Research Report 2025

Code: QYRE-Auto-11B16997
Report
September 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Electroporated Competent Cells Market

The global market for Electroporated Competent Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Electroporated competent cells refer to bacterial cells that have undergone electroporation, a technique used to introduce foreign DNA into cells. Competent cells are cells that have been treated to increase their permeability to DNA, allowing for the uptake of exogenous genetic material.
North American market for Electroporated Competent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Electroporated Competent Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Electroporated Competent Cells include Biosearch Technologies, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Electroporated Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Electroporated Competent Cells.
The Electroporated Competent Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Electroporated Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Electroporated Competent Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Electroporated Competent Cells Market Report

Report Metric Details
Report Name Electroporated Competent Cells Market
Segment by Type
  • Efficient Electroporated Competent Cells
  • Ordinary Electroporated Competent Cells
Segment by Application
  • Pharmaceutical Companies
  • Lab
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biosearch Technologies, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, Zoonbio Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Electroporated Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Electroporated Competent Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Electroporated Competent Cells Market report?

Ans: The main players in the Electroporated Competent Cells Market are Biosearch Technologies, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics, Zoonbio Biotechnology

What are the Application segmentation covered in the Electroporated Competent Cells Market report?

Ans: The Applications covered in the Electroporated Competent Cells Market report are Pharmaceutical Companies, Lab, Others

What are the Type segmentation covered in the Electroporated Competent Cells Market report?

Ans: The Types covered in the Electroporated Competent Cells Market report are Efficient Electroporated Competent Cells, Ordinary Electroporated Competent Cells

1 Electroporated Competent Cells Market Overview
1.1 Product Definition
1.2 Electroporated Competent Cells by Type
1.2.1 Global Electroporated Competent Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 Efficient Electroporated Competent Cells
1.2.3 Ordinary Electroporated Competent Cells
1.3 Electroporated Competent Cells by Application
1.3.1 Global Electroporated Competent Cells Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical Companies
1.3.3 Lab
1.3.4 Others
1.4 Global Electroporated Competent Cells Market Size Estimates and Forecasts
1.4.1 Global Electroporated Competent Cells Revenue 2020-2031
1.4.2 Global Electroporated Competent Cells Sales 2020-2031
1.4.3 Global Electroporated Competent Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Electroporated Competent Cells Market Competition by Manufacturers
2.1 Global Electroporated Competent Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global Electroporated Competent Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Electroporated Competent Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Electroporated Competent Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Electroporated Competent Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Electroporated Competent Cells, Product Type & Application
2.7 Global Key Manufacturers of Electroporated Competent Cells, Date of Enter into This Industry
2.8 Global Electroporated Competent Cells Market Competitive Situation and Trends
2.8.1 Global Electroporated Competent Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Electroporated Competent Cells Players Market Share by Revenue
2.8.3 Global Electroporated Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Electroporated Competent Cells Market Scenario by Region
3.1 Global Electroporated Competent Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Electroporated Competent Cells Sales by Region: 2020-2031
3.2.1 Global Electroporated Competent Cells Sales by Region: 2020-2025
3.2.2 Global Electroporated Competent Cells Sales by Region: 2026-2031
3.3 Global Electroporated Competent Cells Revenue by Region: 2020-2031
3.3.1 Global Electroporated Competent Cells Revenue by Region: 2020-2025
3.3.2 Global Electroporated Competent Cells Revenue by Region: 2026-2031
3.4 North America Electroporated Competent Cells Market Facts & Figures by Country
3.4.1 North America Electroporated Competent Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Electroporated Competent Cells Sales by Country (2020-2031)
3.4.3 North America Electroporated Competent Cells Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Electroporated Competent Cells Market Facts & Figures by Country
3.5.1 Europe Electroporated Competent Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Electroporated Competent Cells Sales by Country (2020-2031)
3.5.3 Europe Electroporated Competent Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Electroporated Competent Cells Market Facts & Figures by Region
3.6.1 Asia Pacific Electroporated Competent Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Electroporated Competent Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific Electroporated Competent Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Electroporated Competent Cells Market Facts & Figures by Country
3.7.1 Latin America Electroporated Competent Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Electroporated Competent Cells Sales by Country (2020-2031)
3.7.3 Latin America Electroporated Competent Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Electroporated Competent Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa Electroporated Competent Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Electroporated Competent Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa Electroporated Competent Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Electroporated Competent Cells Sales by Type (2020-2031)
4.1.1 Global Electroporated Competent Cells Sales by Type (2020-2025)
4.1.2 Global Electroporated Competent Cells Sales by Type (2026-2031)
4.1.3 Global Electroporated Competent Cells Sales Market Share by Type (2020-2031)
4.2 Global Electroporated Competent Cells Revenue by Type (2020-2031)
4.2.1 Global Electroporated Competent Cells Revenue by Type (2020-2025)
4.2.2 Global Electroporated Competent Cells Revenue by Type (2026-2031)
4.2.3 Global Electroporated Competent Cells Revenue Market Share by Type (2020-2031)
4.3 Global Electroporated Competent Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global Electroporated Competent Cells Sales by Application (2020-2031)
5.1.1 Global Electroporated Competent Cells Sales by Application (2020-2025)
5.1.2 Global Electroporated Competent Cells Sales by Application (2026-2031)
5.1.3 Global Electroporated Competent Cells Sales Market Share by Application (2020-2031)
5.2 Global Electroporated Competent Cells Revenue by Application (2020-2031)
5.2.1 Global Electroporated Competent Cells Revenue by Application (2020-2025)
5.2.2 Global Electroporated Competent Cells Revenue by Application (2026-2031)
5.2.3 Global Electroporated Competent Cells Revenue Market Share by Application (2020-2031)
5.3 Global Electroporated Competent Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biosearch Technologies
6.1.1 Biosearch Technologies Company Information
6.1.2 Biosearch Technologies Description and Business Overview
6.1.3 Biosearch Technologies Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biosearch Technologies Electroporated Competent Cells Product Portfolio
6.1.5 Biosearch Technologies Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Company Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck KGaA Electroporated Competent Cells Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Thermo Fisher Scientific Electroporated Competent Cells Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Agilent Technologies
6.4.1 Agilent Technologies Company Information
6.4.2 Agilent Technologies Description and Business Overview
6.4.3 Agilent Technologies Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Agilent Technologies Electroporated Competent Cells Product Portfolio
6.4.5 Agilent Technologies Recent Developments/Updates
6.5 Takara Bio
6.5.1 Takara Bio Company Information
6.5.2 Takara Bio Description and Business Overview
6.5.3 Takara Bio Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takara Bio Electroporated Competent Cells Product Portfolio
6.5.5 Takara Bio Recent Developments/Updates
6.6 Promega Corporation
6.6.1 Promega Corporation Company Information
6.6.2 Promega Corporation Description and Business Overview
6.6.3 Promega Corporation Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Promega Corporation Electroporated Competent Cells Product Portfolio
6.6.5 Promega Corporation Recent Developments/Updates
6.7 Beijing TransGen Biotech
6.7.1 Beijing TransGen Biotech Company Information
6.7.2 Beijing TransGen Biotech Description and Business Overview
6.7.3 Beijing TransGen Biotech Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing TransGen Biotech Electroporated Competent Cells Product Portfolio
6.7.5 Beijing TransGen Biotech Recent Developments/Updates
6.8 GeneScript Corporation
6.8.1 GeneScript Corporation Company Information
6.8.2 GeneScript Corporation Description and Business Overview
6.8.3 GeneScript Corporation Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GeneScript Corporation Electroporated Competent Cells Product Portfolio
6.8.5 GeneScript Corporation Recent Developments/Updates
6.9 Yeastern Biotech
6.9.1 Yeastern Biotech Company Information
6.9.2 Yeastern Biotech Description and Business Overview
6.9.3 Yeastern Biotech Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yeastern Biotech Electroporated Competent Cells Product Portfolio
6.9.5 Yeastern Biotech Recent Developments/Updates
6.10 New England Biolabs
6.10.1 New England Biolabs Company Information
6.10.2 New England Biolabs Description and Business Overview
6.10.3 New England Biolabs Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 New England Biolabs Electroporated Competent Cells Product Portfolio
6.10.5 New England Biolabs Recent Developments/Updates
6.11 QIAGEN N.V.
6.11.1 QIAGEN N.V. Company Information
6.11.2 QIAGEN N.V. Description and Business Overview
6.11.3 QIAGEN N.V. Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.11.4 QIAGEN N.V. Electroporated Competent Cells Product Portfolio
6.11.5 QIAGEN N.V. Recent Developments/Updates
6.12 OriGene Technologies
6.12.1 OriGene Technologies Company Information
6.12.2 OriGene Technologies Description and Business Overview
6.12.3 OriGene Technologies Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.12.4 OriGene Technologies Electroporated Competent Cells Product Portfolio
6.12.5 OriGene Technologies Recent Developments/Updates
6.13 Lucigen
6.13.1 Lucigen Company Information
6.13.2 Lucigen Description and Business Overview
6.13.3 Lucigen Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lucigen Electroporated Competent Cells Product Portfolio
6.13.5 Lucigen Recent Developments/Updates
6.14 Zymo Research
6.14.1 Zymo Research Company Information
6.14.2 Zymo Research Description and Business Overview
6.14.3 Zymo Research Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Zymo Research Electroporated Competent Cells Product Portfolio
6.14.5 Zymo Research Recent Developments/Updates
6.15 Bio-Rad Laboratories
6.15.1 Bio-Rad Laboratories Company Information
6.15.2 Bio-Rad Laboratories Description and Business Overview
6.15.3 Bio-Rad Laboratories Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bio-Rad Laboratories Electroporated Competent Cells Product Portfolio
6.15.5 Bio-Rad Laboratories Recent Developments/Updates
6.16 Bioline
6.16.1 Bioline Company Information
6.16.2 Bioline Description and Business Overview
6.16.3 Bioline Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bioline Electroporated Competent Cells Product Portfolio
6.16.5 Bioline Recent Developments/Updates
6.17 Delphi Genetics
6.17.1 Delphi Genetics Company Information
6.17.2 Delphi Genetics Description and Business Overview
6.17.3 Delphi Genetics Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Delphi Genetics Electroporated Competent Cells Product Portfolio
6.17.5 Delphi Genetics Recent Developments/Updates
6.18 IBA GmBH
6.18.1 IBA GmBH Company Information
6.18.2 IBA GmBH Description and Business Overview
6.18.3 IBA GmBH Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.18.4 IBA GmBH Electroporated Competent Cells Product Portfolio
6.18.5 IBA GmBH Recent Developments/Updates
6.19 Cell Applications
6.19.1 Cell Applications Company Information
6.19.2 Cell Applications Description and Business Overview
6.19.3 Cell Applications Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Cell Applications Electroporated Competent Cells Product Portfolio
6.19.5 Cell Applications Recent Developments/Updates
6.20 BioDynamics Laboratory
6.20.1 BioDynamics Laboratory Company Information
6.20.2 BioDynamics Laboratory Description and Business Overview
6.20.3 BioDynamics Laboratory Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.20.4 BioDynamics Laboratory Electroporated Competent Cells Product Portfolio
6.20.5 BioDynamics Laboratory Recent Developments/Updates
6.21 Scarab Genomics
6.21.1 Scarab Genomics Company Information
6.21.2 Scarab Genomics Description and Business Overview
6.21.3 Scarab Genomics Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Scarab Genomics Electroporated Competent Cells Product Portfolio
6.21.5 Scarab Genomics Recent Developments/Updates
6.22 Zoonbio Biotechnology
6.22.1 Zoonbio Biotechnology Company Information
6.22.2 Zoonbio Biotechnology Description and Business Overview
6.22.3 Zoonbio Biotechnology Electroporated Competent Cells Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Zoonbio Biotechnology Electroporated Competent Cells Product Portfolio
6.22.5 Zoonbio Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Electroporated Competent Cells Industry Chain Analysis
7.2 Electroporated Competent Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Electroporated Competent Cells Production Mode & Process Analysis
7.4 Electroporated Competent Cells Sales and Marketing
7.4.1 Electroporated Competent Cells Sales Channels
7.4.2 Electroporated Competent Cells Distributors
7.5 Electroporated Competent Cells Customer Analysis
8 Electroporated Competent Cells Market Dynamics
8.1 Electroporated Competent Cells Industry Trends
8.2 Electroporated Competent Cells Market Drivers
8.3 Electroporated Competent Cells Market Challenges
8.4 Electroporated Competent Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Electroporated Competent Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Electroporated Competent Cells Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Electroporated Competent Cells Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Electroporated Competent Cells Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Electroporated Competent Cells Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Electroporated Competent Cells Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Electroporated Competent Cells Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Electroporated Competent Cells Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Electroporated Competent Cells, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Electroporated Competent Cells, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Electroporated Competent Cells, Product Type & Application
 Table 12. Global Key Manufacturers of Electroporated Competent Cells, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Electroporated Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electroporated Competent Cells as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Electroporated Competent Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Electroporated Competent Cells Sales by Region (2020-2025) & (K Units)
 Table 18. Global Electroporated Competent Cells Sales Market Share by Region (2020-2025)
 Table 19. Global Electroporated Competent Cells Sales by Region (2026-2031) & (K Units)
 Table 20. Global Electroporated Competent Cells Sales Market Share by Region (2026-2031)
 Table 21. Global Electroporated Competent Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Electroporated Competent Cells Revenue Market Share by Region (2020-2025)
 Table 23. Global Electroporated Competent Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Electroporated Competent Cells Revenue Market Share by Region (2026-2031)
 Table 25. North America Electroporated Competent Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Electroporated Competent Cells Sales by Country (2020-2025) & (K Units)
 Table 27. North America Electroporated Competent Cells Sales by Country (2026-2031) & (K Units)
 Table 28. North America Electroporated Competent Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Electroporated Competent Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Electroporated Competent Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Electroporated Competent Cells Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Electroporated Competent Cells Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Electroporated Competent Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Electroporated Competent Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Electroporated Competent Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Electroporated Competent Cells Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Electroporated Competent Cells Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Electroporated Competent Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Electroporated Competent Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Electroporated Competent Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Electroporated Competent Cells Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Electroporated Competent Cells Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Electroporated Competent Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Electroporated Competent Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Electroporated Competent Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Electroporated Competent Cells Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Electroporated Competent Cells Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Electroporated Competent Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Electroporated Competent Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Electroporated Competent Cells Sales (K Units) by Type (2020-2025)
 Table 51. Global Electroporated Competent Cells Sales (K Units) by Type (2026-2031)
 Table 52. Global Electroporated Competent Cells Sales Market Share by Type (2020-2025)
 Table 53. Global Electroporated Competent Cells Sales Market Share by Type (2026-2031)
 Table 54. Global Electroporated Competent Cells Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Electroporated Competent Cells Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Electroporated Competent Cells Revenue Market Share by Type (2020-2025)
 Table 57. Global Electroporated Competent Cells Revenue Market Share by Type (2026-2031)
 Table 58. Global Electroporated Competent Cells Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Electroporated Competent Cells Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Electroporated Competent Cells Sales (K Units) by Application (2020-2025)
 Table 61. Global Electroporated Competent Cells Sales (K Units) by Application (2026-2031)
 Table 62. Global Electroporated Competent Cells Sales Market Share by Application (2020-2025)
 Table 63. Global Electroporated Competent Cells Sales Market Share by Application (2026-2031)
 Table 64. Global Electroporated Competent Cells Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Electroporated Competent Cells Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Electroporated Competent Cells Revenue Market Share by Application (2020-2025)
 Table 67. Global Electroporated Competent Cells Revenue Market Share by Application (2026-2031)
 Table 68. Global Electroporated Competent Cells Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Electroporated Competent Cells Price (US$/Unit) by Application (2026-2031)
 Table 70. Biosearch Technologies Company Information
 Table 71. Biosearch Technologies Description and Business Overview
 Table 72. Biosearch Technologies Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biosearch Technologies Electroporated Competent Cells Product
 Table 74. Biosearch Technologies Recent Developments/Updates
 Table 75. Merck KGaA Company Information
 Table 76. Merck KGaA Description and Business Overview
 Table 77. Merck KGaA Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck KGaA Electroporated Competent Cells Product
 Table 79. Merck KGaA Recent Developments/Updates
 Table 80. Thermo Fisher Scientific Company Information
 Table 81. Thermo Fisher Scientific Description and Business Overview
 Table 82. Thermo Fisher Scientific Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Thermo Fisher Scientific Electroporated Competent Cells Product
 Table 84. Thermo Fisher Scientific Recent Developments/Updates
 Table 85. Agilent Technologies Company Information
 Table 86. Agilent Technologies Description and Business Overview
 Table 87. Agilent Technologies Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Agilent Technologies Electroporated Competent Cells Product
 Table 89. Agilent Technologies Recent Developments/Updates
 Table 90. Takara Bio Company Information
 Table 91. Takara Bio Description and Business Overview
 Table 92. Takara Bio Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Takara Bio Electroporated Competent Cells Product
 Table 94. Takara Bio Recent Developments/Updates
 Table 95. Promega Corporation Company Information
 Table 96. Promega Corporation Description and Business Overview
 Table 97. Promega Corporation Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Promega Corporation Electroporated Competent Cells Product
 Table 99. Promega Corporation Recent Developments/Updates
 Table 100. Beijing TransGen Biotech Company Information
 Table 101. Beijing TransGen Biotech Description and Business Overview
 Table 102. Beijing TransGen Biotech Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Beijing TransGen Biotech Electroporated Competent Cells Product
 Table 104. Beijing TransGen Biotech Recent Developments/Updates
 Table 105. GeneScript Corporation Company Information
 Table 106. GeneScript Corporation Description and Business Overview
 Table 107. GeneScript Corporation Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. GeneScript Corporation Electroporated Competent Cells Product
 Table 109. GeneScript Corporation Recent Developments/Updates
 Table 110. Yeastern Biotech Company Information
 Table 111. Yeastern Biotech Description and Business Overview
 Table 112. Yeastern Biotech Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Yeastern Biotech Electroporated Competent Cells Product
 Table 114. Yeastern Biotech Recent Developments/Updates
 Table 115. New England Biolabs Company Information
 Table 116. New England Biolabs Description and Business Overview
 Table 117. New England Biolabs Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. New England Biolabs Electroporated Competent Cells Product
 Table 119. New England Biolabs Recent Developments/Updates
 Table 120. QIAGEN N.V. Company Information
 Table 121. QIAGEN N.V. Description and Business Overview
 Table 122. QIAGEN N.V. Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. QIAGEN N.V. Electroporated Competent Cells Product
 Table 124. QIAGEN N.V. Recent Developments/Updates
 Table 125. OriGene Technologies Company Information
 Table 126. OriGene Technologies Description and Business Overview
 Table 127. OriGene Technologies Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. OriGene Technologies Electroporated Competent Cells Product
 Table 129. OriGene Technologies Recent Developments/Updates
 Table 130. Lucigen Company Information
 Table 131. Lucigen Description and Business Overview
 Table 132. Lucigen Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Lucigen Electroporated Competent Cells Product
 Table 134. Lucigen Recent Developments/Updates
 Table 135. Zymo Research Company Information
 Table 136. Zymo Research Description and Business Overview
 Table 137. Zymo Research Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Zymo Research Electroporated Competent Cells Product
 Table 139. Zymo Research Recent Developments/Updates
 Table 140. Bio-Rad Laboratories Company Information
 Table 141. Bio-Rad Laboratories Description and Business Overview
 Table 142. Bio-Rad Laboratories Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bio-Rad Laboratories Electroporated Competent Cells Product
 Table 144. Bio-Rad Laboratories Recent Developments/Updates
 Table 145. Bioline Company Information
 Table 146. Bioline Description and Business Overview
 Table 147. Bioline Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Bioline Electroporated Competent Cells Product
 Table 149. Bioline Recent Developments/Updates
 Table 150. Delphi Genetics Company Information
 Table 151. Delphi Genetics Description and Business Overview
 Table 152. Delphi Genetics Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Delphi Genetics Electroporated Competent Cells Product
 Table 154. Delphi Genetics Recent Developments/Updates
 Table 155. IBA GmBH Company Information
 Table 156. IBA GmBH Description and Business Overview
 Table 157. IBA GmBH Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. IBA GmBH Electroporated Competent Cells Product
 Table 159. IBA GmBH Recent Developments/Updates
 Table 160. Cell Applications Company Information
 Table 161. Cell Applications Description and Business Overview
 Table 162. Cell Applications Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Cell Applications Electroporated Competent Cells Product
 Table 164. Cell Applications Recent Developments/Updates
 Table 165. BioDynamics Laboratory Company Information
 Table 166. BioDynamics Laboratory Description and Business Overview
 Table 167. BioDynamics Laboratory Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. BioDynamics Laboratory Electroporated Competent Cells Product
 Table 169. BioDynamics Laboratory Recent Developments/Updates
 Table 170. Scarab Genomics Company Information
 Table 171. Scarab Genomics Description and Business Overview
 Table 172. Scarab Genomics Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Scarab Genomics Electroporated Competent Cells Product
 Table 174. Scarab Genomics Recent Developments/Updates
 Table 175. Zoonbio Biotechnology Company Information
 Table 176. Zoonbio Biotechnology Description and Business Overview
 Table 177. Zoonbio Biotechnology Electroporated Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Zoonbio Biotechnology Electroporated Competent Cells Product
 Table 179. Zoonbio Biotechnology Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Electroporated Competent Cells Distributors List
 Table 183. Electroporated Competent Cells Customers List
 Table 184. Electroporated Competent Cells Market Trends
 Table 185. Electroporated Competent Cells Market Drivers
 Table 186. Electroporated Competent Cells Market Challenges
 Table 187. Electroporated Competent Cells Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Electroporated Competent Cells
 Figure 2. Global Electroporated Competent Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Electroporated Competent Cells Market Share by Type: 2024 & 2031
 Figure 4. Efficient Electroporated Competent Cells Product Picture
 Figure 5. Ordinary Electroporated Competent Cells Product Picture
 Figure 6. Global Electroporated Competent Cells Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Electroporated Competent Cells Market Share by Application: 2024 & 2031
 Figure 8. Pharmaceutical Companies
 Figure 9. Lab
 Figure 10. Others
 Figure 11. Global Electroporated Competent Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Electroporated Competent Cells Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Electroporated Competent Cells Sales (2020-2031) & (K Units)
 Figure 14. Global Electroporated Competent Cells Average Price (US$/Unit) & (2020-2031)
 Figure 15. Electroporated Competent Cells Report Years Considered
 Figure 16. Electroporated Competent Cells Sales Share by Manufacturers in 2024
 Figure 17. Global Electroporated Competent Cells Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Electroporated Competent Cells Players: Market Share by Revenue in Electroporated Competent Cells in 2024
 Figure 19. Electroporated Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Electroporated Competent Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Electroporated Competent Cells Sales Market Share by Country (2020-2031)
 Figure 22. North America Electroporated Competent Cells Revenue Market Share by Country (2020-2031)
 Figure 23. United States Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Electroporated Competent Cells Sales Market Share by Country (2020-2031)
 Figure 26. Europe Electroporated Competent Cells Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Electroporated Competent Cells Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Electroporated Competent Cells Revenue Market Share by Region (2020-2031)
 Figure 34. China Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Electroporated Competent Cells Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Electroporated Competent Cells Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Electroporated Competent Cells Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Electroporated Competent Cells Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Electroporated Competent Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Electroporated Competent Cells by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Electroporated Competent Cells by Type (2020-2031)
 Figure 53. Global Electroporated Competent Cells Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Electroporated Competent Cells by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Electroporated Competent Cells by Application (2020-2031)
 Figure 56. Global Electroporated Competent Cells Price (US$/Unit) by Application (2020-2031)
 Figure 57. Electroporated Competent Cells Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network